
5319. urinary porter-silber chromogens 
following intravenous metho- 
pyrapone acth patients breast cancer 
urinary porter-silber chromogens 
measured 2 groups patients 
breast cancer before, 
intravenous methopyrapone 
acth administration.  control group 
consisted females free disease 
5 years following mastectomy 
study group documented 
metastatic disease.  significant difference 
urinary porter-silber chromo- 
gens found 2 groups day 
course study 
within range normal measured 
laboratory.  concluded 
functional reserve capacity 
pituitary acth secretion adreno- 
cortical steroidogenesis patients 
advanced metastatic breast cancer rela- 
tively normal. 
